Founded in 2012, MindMaze is a global leader in brain technology with a mission to accelerate humanity’s ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, biosensing, engineering, mixed reality and artificial intelligence, we have enhanced the recovery potential of patients with neurological diseases.

Combining our FDA cleared and CE marked digital therapeutics with best-in-class motion analytics, AI and cloud technologies, our goal is to create the universal platform for brain health.

Expanding our impact beyond healthcare, MindMaze Labs is our enterprising R&D division tasked with bringing our ground-breaking neuroscience to everyday life. By harnessing the power of the brain, our neurotechnology will empower the next generation of human-machine interfaces.

MindMaze is pioneering digital neurotherapeutics and teleneurorehabilitation, creating a universal solution for brain health and recovery. Their innovative therapies and technologies aim to enhance neurorehabilitation and cognitive recovery for patients with neurological conditions. MindMaze is focused on transforming care for neurological diseases through a combination of medical-grade software, tailored content, AI, motion analytics, and proprietary peripherals.

The company is committed to expanding its impact from healthcare into everyday life applications via its Labs division, driving advancements in neuroscience and technology to unlock human potential.